Literature DB >> 2060761

Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis.

A Ray1, K Redhead, S Selkirk, S Poole.   

Abstract

Comparison of lipopolysaccharides (LPS) from phase variants of different strains of Bordetella phase variants of different strains of Bordetella pertussis has shown a difference in their composition, antigenicity and reactogenicity. Phase I variants of B. pertussis, with the exception of strain 134, contain a preponderance of LPS I whereas the major component of LPS of phase IV variants is LPS II. Sera raised to LPSs of phase I strains, other than 134, cross-react with each other but not with phase IV LPSs; and similarly all sera raised to phase IV LPSs cross-react with each other and with LPS from 134 phase I. The LPSs of all phase I variants, including that of 134, are approximately ten-fold or more reactive in the limulus amoebocyte lysate assay (LAL) than phase IV LPSs. In the human mononuclear cell pyrogen assay phase IV LPSs also stimulated a lower response than phase I LPSs. The B. pertussis phase I LPSs are 10-times more reactive than Escherichia coli standard endotoxin in the LAL assay but 100-times less reactive than E. coli LPS in the monocyte test for pyrogen. The SDS-PAGE profiles of B. pertussis LPSs are quite different from those of B. parapertussis and B. bronchiseptica strains. B. pertussis LPSs produced a typical lipo-oligosaccharide (LOS) pattern. B. bronchiseptica LPS produced a similar pattern but was antigenically distinct from B. pertussis LPSs I and II. B. parapertussis in contrast produced a ladder pattern typical of smooth type LPS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060761     DOI: 10.1016/0378-1097(91)90088-r

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Variability in PolyIC induced immune response: Implications for preclinical maternal immune activation models.

Authors:  Milo Careaga; Sandra L Taylor; Carolyn Chang; Alex Chiang; Katherine M Ku; Robert F Berman; Judy A Van de Water; Melissa D Bauman
Journal:  J Neuroimmunol       Date:  2018-06-28       Impact factor: 3.478

Review 3.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

4.  In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.

Authors:  Federico Sisti; Julieta Fernández; María Eugenia Rodríguez; Antonio Lagares; Nicole Guiso; Daniela Flavia Hozbor
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Demonstration of lipopolysaccharide with O-polysaccharide chains among different heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels.

Authors:  D C Blake; R G Russell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin.

Authors:  M Caroff; C Deprun; J C Richards; D Karibian
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

8.  Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae.

Authors:  J P van Putten
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

9.  Contrasting patterns of polymorphism and selection in bacterial-sensing toll-like receptor 4 in two house mouse subspecies.

Authors:  Alena Fornuskova; Josef Bryja; Michal Vinkler; Miloš Macholán; Jaroslav Piálek
Journal:  Ecol Evol       Date:  2014-06-20       Impact factor: 2.912

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.